Jinhua Xu Selected Research

Syphilis

7/2007	Occurrence of congenital syphilis after maternal treatment with azithromycin during pregnancy.
8/2005	A study evaluating ceftriaxone as a treatment agent for primary and secondary syphilis in pregnancy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jinhua Xu Research Topics

Disease

21	Neoplasms (Cancer) 03/2024 - 12/2005
19	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2024 - 01/2013
14	Melanoma (Melanoma, Malignant) 01/2022 - 09/2012
13	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2023 - 06/2011
9	Inflammation (Inflammations) 05/2024 - 12/2011
7	Vitiligo 03/2024 - 12/2018
6	Infections 01/2022 - 06/2017
5	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2015
5	Breast Neoplasms (Breast Cancer) 01/2019 - 09/2008
4	Atopic Dermatitis (Atopic Eczema) 12/2023 - 12/2011
3	Skin Diseases (Skin Disease) 01/2023 - 12/2017
3	Chronic Urticaria 01/2022 - 01/2015
3	Triple Negative Breast Neoplasms 01/2022 - 01/2015
3	Fibrosis (Cirrhosis) 04/2021 - 04/2016
2	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 09/2023
2	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 02/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2021
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 02/2019
2	Dermatitis 10/2021 - 07/2021
2	Disease Resistance 01/2021 - 01/2020
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 03/2017
2	Allergic Rhinitis 12/2019 - 12/2011
2	Asthma (Bronchial Asthma) 12/2019 - 12/2011
2	Psoriatic Arthritis 01/2019 - 03/2017
2	Wounds and Injuries (Trauma) 01/2018 - 01/2015
2	Reperfusion Injury 01/2018 - 02/2015
2	Eczema 12/2017 - 11/2016
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 08/2017 - 10/2009
2	Elastosis perforans serpiginosa 07/2016 - 03/2015
2	Porokeratosis (Palmoplantar Porokeratosis) 01/2016 - 07/2015
2	Alopecia (Baldness) 01/2016 - 01/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2014 - 08/2013
2	Retinoblastoma (Glioblastoma, Retinal) 11/2009 - 02/2009
2	Syphilis 07/2007 - 08/2005
1	Carcinoma (Carcinomatosis) 03/2024
1	Lupus Nephritis 01/2024

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 05/2024 - 04/2016
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2009
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2011
5	SalicylatesIBA 03/2024 - 05/2017
5	Long Noncoding RNAIBA 12/2023 - 01/2020
5	baohuoside IIBA 01/2020 - 09/2012
4	CopperIBA 03/2024 - 05/2017
4	Interleukin-6 (Interleukin 6)IBA 12/2023 - 01/2019
4	SurvivinIBA 09/2023 - 05/2017
4	Messenger RNA (mRNA)IBA 08/2021 - 06/2010
4	CateninsIBA 11/2020 - 01/2015
3	Imiquimod (Aldara)FDA LinkGeneric 05/2024 - 01/2021
3	PhenanthrolinesIBA 03/2024 - 06/2023
3	Monoclonal AntibodiesIBA 01/2024 - 01/2022
3	spesolimabIBA 12/2023 - 01/2021
3	Immunoglobulin G (IgG)IBA 01/2023 - 04/2021
3	ChemokinesIBA 01/2022 - 10/2013
3	AutoantibodiesIBA 01/2022 - 11/2016
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 10/2018
3	EnzymesIBA 11/2020 - 08/2017
3	AntioxidantsIBA 11/2020 - 01/2018
3	Small Interfering RNA (siRNA)IBA 08/2017 - 01/2015
3	DNA (Deoxyribonucleic Acid)IBA 09/2013 - 06/2011
2	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2024 - 04/2021
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2023 - 11/2021
2	Immunoglobulin E (IgE)IBA 01/2023 - 01/2022
2	Acitretin FDA Link 01/2023 - 01/2022
2	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 01/2019
2	AntigensIBA 01/2022 - 03/2017
2	InterleukinsIBA 01/2022 - 04/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2021
2	Circular RNAIBA 01/2022 - 01/2021
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2021 - 03/2015
2	CreatinineIBA 04/2021 - 10/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2021 - 01/2013
2	Azithromycin (Zithromax)FDA LinkGeneric 04/2021 - 07/2007
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2020
2	AntibodiesIBA 12/2020 - 01/2015
2	Therapeutic UsesIBA 12/2020 - 11/2019
2	NucleotidesIBA 01/2020 - 01/2014
2	Melanins (Melanin)IBA 12/2019 - 11/2016
2	CollagenIBA 02/2019 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 09/2012
2	Interleukin-8 (Interleukin 8)IBA 12/2017 - 09/2012
2	MicroRNAs (MicroRNA)IBA 02/2017 - 01/2017
2	Penicillamine (Cuprimine)FDA Link 07/2016 - 03/2015
2	Mevalonic Acid (Mevalonate)IBA 01/2016 - 07/2015
2	HLA-B Antigens (HLA-B)IBA 01/2016 - 08/2014
2	epimedii flavoneIBA 01/2013 - 09/2012
2	Transcription Factors (Transcription Factor)IBA 01/2013 - 04/2010
2	MethyltransferasesIBA 01/2013 - 06/2011
2	Penicillins (Penicillin)FDA Link 07/2007 - 08/2005
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 05/2024
1	InterferonsIBA 03/2024
1	Interleukin-12 (IL 12)IBA 03/2024
1	Gallic AcidIBA 03/2024
1	Tight Junction ProteinsIBA 03/2024
1	LipopolysaccharidesIBA 03/2024
1	tildrakizumabIBA 01/2024
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2024

Therapy/Procedure

15	Therapeutics 03/2024 - 10/2009
4	Immunotherapy 01/2022 - 12/2019
2	Phototherapy (Light Therapy) 01/2023 - 01/2021
2	Photochemotherapy (Photodynamic Therapy) 09/2021 - 03/2021